
Lo mhlahlandlela ophelele uhlola i-pathology ye-renal cell carcinoma (RCC), ucubungula ezinhlotsheni zayo ezihlukahlukene, izindlela zokuxilonga, kanye nemithelela yamasu okwelapha. Sihlola izici ezincane kakhulu, izinguquko zofuzo, nezici zokubikezela ezihlotshaniswa ne-RCC, sinikeza ukuqonda okuningiliziwe kochwepheshe bezokunakekelwa kwempilo nabacwaningi.
I-Renal cell carcinoma, uhlobo oluvame kakhulu lomdlavuza wezinso, luvela olwelweni lwamashubhu ezinso. Kukhona ama-subtypes amaningana, ngalinye linezici ezihlukile ze-pathological kanye nokuziphatha komtholampilo. Lokhu kufaka i-clear cell RCC (ccRCC), i-papillary RCC (pRCC), i-chromophobe RCC (chRCC), nezinye. I-subtyping enembile ibalulekile ekuqondiseni ukwelashwa kwe-renal cell carcinoma pathology nokubikezela isibikezelo. Ukuhlukaniswa okunembile kuncike ekuhloleni ngokucophelela kwe-microscopic kanye ne-immunohistochemical staining, ngokuvamile edinga ubuchwepheshe ku-genitourinary pathology.
Ukuxilongwa kwe-RCC kusekelwe ngokuyinhloko ekuhlolweni kwe-histopathological yamasampula ezicubu ezitholwe nge-biopsy noma ukukhishwa kabusha kokuhlinzwa. Izici ezicacile ze-microscopic, njenge-cell morphology, izici zenuzi, namaphethini okukhula, zisiza ukuhlukanisa phakathi kwe-RCC subtypes. Isibonelo, i-ccRCC ibonakala nge-cytoplasm ecacile, kuyilapho i-pRCC ibonisa ukwakheka kwe-papillary. I-Immunohistochemistry idlala indima ebalulekile ekuqinisekiseni ukuxilongwa kanye nokuhlonza ama-subtypes athile, okusiza ukucwenga. ukwelashwa kwe-renal cell carcinoma pathology izinhlelo.
Ukungajwayelekile kwezakhi zofuzo kudlala indima ebalulekile ekuthuthukisweni nasekuqhubekeleni phambili kwe-RCC. Izinguquko ezivame kakhulu zofuzo zibandakanya isakhi sofuzo sokucindezela isisu se-von Hippel-Lindau (VHL), ikakhulukazi ku-ccRCC. Ezinye izakhi zofuzo, ezifana ne-PBRM1, BAP1, ne-SETD2, nazo zivame ukuguqulwa ezinhlotsheni ezincane ze-RCC. Ukuqonda lezi zinguquko zofuzo kubalulekile ekuthuthukiseni izindlela zokwelapha ezihlosiwe kanye nokwenza ngcono imiphumela yesiguli. Izindlela ezithuthukisiwe zamangqamuzana, njengokulandelanisa isizukulwane esilandelayo, ziya ngokuya zisetshenziswa ukukhomba lezi zinguquko, ukwazisa ukwelashwa kwe-renal cell carcinoma pathology sondela.
Ukuhlonzwa kokuguqulwa kofuzo okuthile ku-RCC kuholele ekuthuthukisweni kwezindlela zokwelapha ezihlosiwe. Isibonelo, ama-inhibitors e-vascular endothelial growth factor (VEGF) kanye nethagethi ye-mammalian ye-rapamycin (mTOR) avame ukusetshenziswa ku-RCC ethuthukisiwe, ikakhulukazi lawo anokuguqulwa kwe-VHL. Lawa ma-ejenti ahlosiwe ngokuvamile abonisa inzuzo ebalulekile yomtholampilo futhi athuthukise amazinga okusinda. Ucwaningo oluqhubekayo lwezisekelo zamangqamuzana e-RCC luyaqhubeka nokuvula indlela yezindlela zokwelapha ezihlosiwe ezisebenza ngempumelelo kanye namasu okwelapha aqondene nawe.
Izinto ezimbalwa zithonya ukubikezelwa kwe-RCC, kufaka phakathi isigaba sesimila, ibanga, kanye ne-subtype. Ukuba khona kwesifo se-metastatic kuthinta kakhulu amazinga okusinda. Izici ze-pathological, njengebanga lenuzi kanye ne-necrosis, nazo zinomthelela ekuhlukaniseni okubikezelwe. Lokhu kuhlolwa okuningiliziwe kwe-pathological kubalulekile ekuqondiseni izinqumo zokwelashwa kanye nokuhlanganisa izindlela zokwelapha zesiguli ngasinye. Ukukhethwa kwe ukwelashwa kwe-renal cell carcinoma pathology kuncike kakhulu kulokhu kuhlola.
Amasu okwelapha e-RCC ayahluka kuye ngesiteji kanye nebanga lesifo. Ukukhishwa kabusha ngokuhlinzwa kuwukwelashwa okuyinhloko kwe-RCC yendawo. Nge-RCC ethuthukisiwe noma ye-metastatic, izindlela zokwelapha ezihleliwe njengama-ejenti ahlosiwe noma i-immunotherapy ziyasetshenziswa. Ukukhethwa kokwelashwa kuvame ukuqondiswa uhlobo oluncane lwe-pathological, ukuguqulwa kofuzo, kanye nempilo yesiguli iyonke. Ucwaningo oluqhubekayo luhlola izindlela zokwelapha ezintsha, ezithuthukisa ukuqonda kwethu okwandayo kwezinqubo zamangqamuzana eziqhuba ukuthuthukiswa kwe-RCC.
I-Immunohistochemistry (IHC) iyithuluzi eliyigugu ku-RCC pathology. Omaka abathile, njenge-VHL, AMACR, ne-PAX8, basetshenziselwa ukuhlonza izinhlobo ezincane ze-RCC futhi ziwahlukanise kwamanye amathumba ezinso. I-IHC ingasiza futhi ekuhloleni ibanga lesimila kanye nokubikezela ukubikezelwa. Ngaphezu kwalokho, i-IHC idlala indima ebalulekile ekuhlonzeni izinhloso zokwelapha ezingaba khona, ukwazisa komuntu siqu. ukwelashwa kwe-renal cell carcinoma pathology izinqumo.
Amasu athuthukile wamamolekyuli, njengokulandelanisa kwesizukulwane esilandelayo (NGS) kanye ne-fluorescence in situ hybridization (FISH), aya ngokuya asetshenziswa ku-RCC pathology. I-NGS ivumela ukuhlonza iphrofayili yofuzo ebanzi, ehlonza izinhlobonhlobo zezinguquko zofuzo ezingaba nomthelela ekukhethweni kokwelashwa futhi zibikezele impendulo ekwelashweni. I-FISH ingathola okungavamile kwe-chromosomal, inikeze imininingwane eyengeziwe kubhayoloji yesimila kanye nokubikezela.
Ulwazi olunikezwe lapha ngelezinjongo zokufundisa kuphela futhi aluhlanganisi iseluleko sezokwelapha. Ukuze uthole ukuxilongwa nokwelashwa kwe-renal cell carcinoma, sicela uthintane nochwepheshe bezempilo abaqeqeshiwe.
Ukuze uthole ulwazi olwengeziwe nokwesekwa, cabangela ukuvakashela i- I-Shandong Baofa Cancer Research Institute iwebhusayithi. Banikeza izinsiza ezibalulekile kanye nobuchwepheshe ekunakekelweni komdlavuza.
eceleni>